Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma

NCT02315716

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Queen's Hospital Romford, Essex, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • NHS Lanarkshire Bothwell, United Kingdom
View all 20 locations
View Trial Details
Active, not recruiting

Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)

NCT02406222

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University of Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • Royal Sussex County Hospital Brighton, United Kingdom
View all 21 locations
View Trial Details
Active, not recruiting

Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A

NCT03432520

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Mississippi Center for Advanced Medicine Madison, Mississippi, United States
  • Truman Medical Centers Kansas City, Missouri, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Active, not recruiting

A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

NCT03989414

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 119 Denver, Colorado, United States
  • Local Institution - 104 Tampa, Florida, United States
  • Local Institution - 108 Atlanta, Georgia, United States
  • Local Institution - 112 Chicago, Illinois, United States
View all 49 locations
View Trial Details
Active, not recruiting

Critical Care Outcomes of Hematologic Oncology Patients

NCT03449953

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +4 more
Locations
  • Foothills Hospital Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • University of Manitoba Winnipeg, Manitoba, Canada
View all 13 locations
View Trial Details
Active, not recruiting

Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia

NCT04147533

Conditions
Bone Marrow Diseases, Chemically-Induced Disorders, Chronic Disease, +17 more
Locations
  • University Hospital Brno Brno, Czechia
  • University Hospital Hradec Kralove Hradec Králové, Czechia
  • University Hospital Olomouc Olomouc, Czechia
  • University Hospital Ostrava Ostrava, Czechia
View Trial Details

Related conditions